Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
Robert Hughes, Todd Bosanac, Xianrong Mao, et al.
Cell Reports (2021) Vol. 34, Iss. 1, pp. 108588-108588
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration
Matthew D. Figley, Weixi Gu, Jeffrey D. Nanson, et al.
Neuron (2021) Vol. 109, Iss. 7, pp. 1118-1136.e11
Open Access | Times Cited: 258
The landscape of aging
Yusheng Cai, Wei Song, Jiaming Li, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 12, pp. 2354-2454
Open Access | Times Cited: 240
Reducing acetylated tau is neuroprotective in brain injury
Min-Kyoo Shin, Edwin Vázquez‐Rosa, Yeojung Koh, et al.
Cell (2021) Vol. 184, Iss. 10, pp. 2715-2732.e23
Open Access | Times Cited: 143
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
Ines Klein, Helmar C. Lehmann
Toxics (2021) Vol. 9, Iss. 10, pp. 229-229
Open Access | Times Cited: 115
Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy
Todd Bosanac, Robert Hughes, Thomas M. Engber, et al.
Brain (2021) Vol. 144, Iss. 10, pp. 3226-3238
Open Access | Times Cited: 110
Shared TIR enzymatic functions regulate cell death and immunity across the tree of life
Kow Essuman, Jeffrey Milbrandt, Jeffery L. Dangl, et al.
Science (2022) Vol. 377, Iss. 6605
Closed Access | Times Cited: 101
Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules
Yun Shi, Philip S. Kerry, Jeffrey D. Nanson, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1643-1659.e10
Open Access | Times Cited: 88
Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients
A. Joseph Bloom, Xianrong Mao, Amy Strickland, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 86
Targeting synapse function and loss for treatment of neurodegenerative diseases
Borislav Dejanovic, Morgan Sheng, Jesse E. Hanson
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 23-42
Closed Access | Times Cited: 44
Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism
Yue Huang, Mi Shao, Xinyi Teng, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101400-101400
Open Access | Times Cited: 19
Sarm1 activation produces cADPR to increase intra-axonal Ca++ and promote axon degeneration in PIPN
Yihang Li, Maria F. Pazyra‐Murphy, Daina Avizonis, et al.
The Journal of Cell Biology (2021) Vol. 221, Iss. 2
Open Access | Times Cited: 65
Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders
Jonathan Gilley, Oscar Jackson, Menelaos Pipis, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 63
Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies
Marina Stavrou, Irene Sargiannidou, Elena Georgiou, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6048-6048
Open Access | Times Cited: 57
Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain
Hannah C. Feldman, Elisa Merlini, Carlos Guijas, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 35
Open Access | Times Cited: 56
Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity
Yao Hong, Minghui Liu, Leibo Wang, et al.
Cell Research (2022) Vol. 32, Iss. 6, pp. 570-584
Open Access | Times Cited: 41
Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease
Matthew Bratkowski, Thomas C. Burdett, Jean Danao, et al.
Neuron (2022) Vol. 110, Iss. 22, pp. 3711-3726.e16
Open Access | Times Cited: 38
Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence
Susanna B. Park, Aysel Cetinkaya‐Fisgin, Andreas A. Argyriou, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 94, Iss. 11, pp. 962-972
Open Access | Times Cited: 32
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies
Alessandra Bolino, Maurizio D’Antonio
Journal of the Peripheral Nervous System (2023) Vol. 28, Iss. 2, pp. 134-149
Open Access | Times Cited: 23
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives
Claudia Alberti, Federica Rizzo, Alessia Anastasia, et al.
Neurobiology of Disease (2024) Vol. 193, pp. 106467-106467
Open Access | Times Cited: 15
Regulation of and challenges in targeting NAD+ metabolism
Marie E. Migaud, Mathias Ziegler, Joseph A. Baur
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 10, pp. 822-840
Closed Access | Times Cited: 13
Targeted protein relocalization via protein transport coupling
Christine S.C. Ng, Aofei Liu, Bianxiao Cui, et al.
Nature (2024)
Closed Access | Times Cited: 12
Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate
Wan Hua Li, Ke Huang, Yang Cai, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 54
Mitochondrial dysfunction as a trigger of programmed axon death
Elisa Merlini, Michael P. Coleman, Andrea Loreto
Trends in Neurosciences (2021) Vol. 45, Iss. 1, pp. 53-63
Closed Access | Times Cited: 46
The balance between NAD+ biosynthesis and consumption in ageing
Øyvind Strømland, Joseph Diab, Eugenio Ferrario, et al.
Mechanisms of Ageing and Development (2021) Vol. 199, pp. 111569-111569
Open Access | Times Cited: 42
A SARM1-mitochondrial feedback loop drives neuropathogenesis in a Charcot-Marie-Tooth disease type 2A rat model
Yurie Yamada, Amy Strickland, Yo Sasaki, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 23
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top